Ghost Tree Capital’s Novavax NVAX Stock Holding History

Ghost Tree Capital’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-20,000	Closed	-$832K	–	86
2016 Q3	$832K	Buy	+20,000	New	+$2.58M	0.13%	81

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ghost Tree Capital's NVAX Position: Q2 2021 in Review

Ghost Tree Capital sold out of Novavax (NVAX) in Q2 2021, closing a stake of 17,500 shares — an estimated $3.17M sold.

Ghost Tree Capital first reported a position in NVAX in Q1 2014 and held it in 2 quarters. The position peaked at $3.17M in Q1 2021. 407 funds tracked by Wall St. Rank hold NVAX as of Q2 2021.

Ghost Tree Capital reported no remaining Novavax position as of Q2 2021 after selling out during the quarter.
Ghost Tree Capital sold 17,500 Novavax shares in Q2 2021, an estimated $3.17M.
Ghost Tree Capital first reported a position in Novavax in Q1 2014 and held it in 2 quarters.
Ghost Tree Capital's Novavax position peaked at $3.17M in Q1 2021.
407 funds tracked by Wall St. Rank held Novavax as of Q2 2021.

Based on Ghost Tree Capital's 13F filing for Q2 2021, filed 11 Aug 2021.